GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NurExone Biologic Inc (FRA:J90) » Definitions » Net Interest Income

NurExone Biologic (FRA:J90) Net Interest Income : €0.03 Mil (TTM As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is NurExone Biologic Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. NurExone Biologic's net interest income for the three months ended in Sep. 2024 was €0.03 Mil. Its net interest income for the trailing twelve months (TTM) ended in Sep. 2024 was €0.03 Mil.

NurExone Biologic Net Interest Income Historical Data

The historical data trend for NurExone Biologic's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NurExone Biologic Net Interest Income Chart

NurExone Biologic Annual Data
Trend Dec21 Dec22 Dec23
Net Interest Income
-0.01 -0.02 0.04

NurExone Biologic Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 - - -0.01 0.03

NurExone Biologic Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NurExone Biologic Net Interest Income Related Terms

Thank you for viewing the detailed overview of NurExone Biologic's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

NurExone Biologic Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NurExone Biologic Inc (FRA:J90) » Definitions » Net Interest Income
Comparable Companies
TSXV:TTI TSX:HBP TSXV:GSD NEOE:BMND TSXV:HEM XCNQ:DOSE TSX:BCT TSXV:SHRX XCNQ:MDMA XCNQ:GLAB VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
NRXBF:USA NRX:Canada
Address
1 Adelaide St. East, Suite 801, Toronto, ON, CAN, M5C 2V9
Website
https://www.nurexone.com
NurExone Biologic Inc is a company that focuses on developing innovative, biological and minimally invasive treatments for Spinal Cord Injury and Traumatic Brain Injury. Their primary product is ExoTherapy, which is an exosome therapy production platform. The company has two business lines. Firstly, it is developing ExoPTEN, a product that utilizes ExoTherapy for the treatment of acute Spinal Cord Injuries (SCI). Secondly, it aims to monetize its proprietary ExoTherapy technology and production platform by licensing it to the global biopharmaceutical industry for other diseases and indications.

NurExone Biologic Headlines

No Headlines